![](/img/cover-not-exists.png)
Phase I/II Trial for Patients with Advanced Hematologic Malignancies Undergoing Myeloablative Allogeneic HCT with a T Cell Depleted Graft with Infusion of Conventional T Cells and Regulatory T Cells
Meyer, Everett, Laport, Ginna G., Tantsura, Ilia, Tang, Sai Wen, Sahaf, Bita, Rangarajan, Krish, Armstrong, Randall, Tate, Keri, Tudisco, Cynthia, Sheehan, Kevin, Arai, Sally, Johnston, Laura, Muffly,Volume:
24
Language:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2017.12.102
Date:
March, 2018
File:
PDF, 104 KB
english, 2018